Article
Lipidated macrocyclic peptide S-880008 as a broad-spectrum SARS-CoV-2 fusion inhibitor
2025-02-14
Abstract excerpt
<title>Abstract</title> <p>Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a threat to public health and the economy. Although several SARS-CoV-2 vaccines exist, they have failed to elicit effective neutralizing antibody responses against emerging SARS-CoV-2 variants harboring spike protein mutations. Moreover, while certain neutralizing-antibody-based the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 456cceb3-49d1-5049-bc4b-967e6e9bfd99
- DOI
- 10.21203/rs.3.rs-5977541/v1
